Lacosamide.
Article Details
- CitationCopy to clipboard
Perucca E, Yasothan U, Clincke G, Kirkpatrick P
Lacosamide.
Nat Rev Drug Discov. 2008 Dec;7(12):973-4. doi: 10.1038/nrd2764.
- PubMed ID
- 19043448 [ View in PubMed]
- Abstract
In August 2008, lacosamide (Vimpat; UCB), was granted market authorization by the European Commission as an adjunctive therapy for partial-onset seizures with or without secondary generalization in patients with epilepsy. It was approved by the FDA as an adjunctive therapy for partial-onset seizures in October 2008.
DrugBank Data that Cites this Article
- Drugs